The US Food and Drug Administration (FDA) has announced it will re-evaluate the regulatory status of several widely discussed therapeutic peptides, including BPC-157, KPV and Semax
PMID: 29730720
By: Sean Moloughney Editor, Nutraceuticals World Booth 761 For nearly a half century, KOHJIN Life Sciences, a Mitsubishi Corporation Group Company, has been a global leader in the research and development of L-Glutathione (GSH), the tripeptide found in every human cell that promotes cell health and regeneration, and which the body loses over time, accelerating the aging process and putting health and immunity at risk
She is dedicated to providing you with comprehensive information so that you can make an informed decision and avoid purchasing a home that isn't right for you
The study documented BPC-157's neuroprotective effects in the central nervous system, extending the peptide's documented tissue-protective properties beyond peripheral tissues to include spinal cord repair